D-0196-2026 Class II Ongoing

Recalled by CA BOTANA International, Inc. — San Diego, CA

FDA drug recall D-0196-2026 was initiated by CA BOTANA International, Inc. on Oct 10, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 4890 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 3, 2025
Initiation Date
Oct 10, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4890 bottles

Product description

Dr. Bump Natural Pain Relief Gel, Menthol 5%, NET WT 4 FL OZ/118 ML per bottle, Distr. by 1Beauty US LLC, Palm Desert, CA 92211. NDC: 35192-052-18, UPC 8 18204 02513 8

Reason for recall

CGMP Deviations

Distribution pattern

CA, CO, FL, PR, WA

Code information

Lot D54947, exp 4/30/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0196-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0196-2026. Report a data issue: hello@regdatalab.com.